These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 38887309)

  • 1. Peripheral blood platelet counts identify prognostically diverse clinical phenotypes in hepatocellular carcinoma.
    Carr BI; Bag HG; Yilmaz S
    Ann Gastroenterol Dig Syst; 2024; 7(1):. PubMed ID: 38887309
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Significance of platelet and AFP levels and liver function parameters for HCC size and survival.
    Carr BI; Guerra V; Giannini EG; Farinati F; Ciccarese F; Rapaccini GL; Di Marco M; Benvegnù L; Zoli M; Borzio F; Caturelli E; Chiaramonte M; Trevisani F;
    Int J Biol Markers; 2014 Sep; 29(3):e215-23. PubMed ID: 24526315
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HCC with low- and normal-serum alpha-fetoprotein levels.
    Carr BI; Akkiz H; Üsküdar O; Yalçın K; Guerra V; Kuran S; Karaoğullarından Ü; Altıntaş E; Özakyol A; Tokmak S; Ballı T; Yücesoy M; Bahçeci Hİ; Ülkü A; Akçam T; Polat KY; Ekinci N; Şimşek H; Örmeci N; Sonsuz A; Demir M; Kılıç M; Uygun A; Demir A; Delik A; Arslan B; Doran F; Yilmaz S; Tokat Y
    Clin Pract (Lond); 2018; 15(1):453-464. PubMed ID: 29576865
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CRP is a superior and prognostically significant inflammation biomarker for hepatocellular cancer patients treated by liver transplantation.
    Carr BI; Ince V; Bag HG; Usta S; Ersan V; Isik B; Yilmaz S
    Clin Pract (Lond); 2021; 18(2):1626-1632. PubMed ID: 33972830
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Low alpha-fetoprotein HCC and the role of GGTP.
    Carr BI; Guerra V; Giannini EG; Farinati F; Ciccarese F; Rapaccini GL; Di Marco M; Benvegnù L; Zoli M; Borzio F; Caturelli E; Chiaramonte M; Trevisani F
    Int J Biol Markers; 2014 Dec; 29(4):e395-402. PubMed ID: 24832180
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of two clinical hepatocellular carcinoma patient phenotypes from results of standard screening parameters.
    Carr BI; Pancoska P; Giannini EG; Farinati F; Ciccarese F; Rapaccini GL; Marco MD; Benvegnù L; Zoli M; Borzio F; Caturelli E; Chiaramonte M; Trevisani F;
    Semin Oncol; 2014 Jun; 41(3):406-414. PubMed ID: 25023357
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Platelet-related phenotypic patterns in hepatocellular carcinoma patients.
    Carr BI; Lin CY; Lu SN
    Semin Oncol; 2014 Jun; 41(3):415-21. PubMed ID: 25023358
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characteristics of Hepatocellular Carcinoma Aggressiveness Factors in Turkish Patients.
    Akkiz H; Carr BI; Yalçın K K; Guerra V; Kuran S; Altıntaş E; Üsküdar O; Karaoğullarından Ü; Özakyol A; Tokmak S; Yücesoy M; Bahçeci Hİ; Ülkü A; Akçam T; Yalçın Polat K; Ekinci N; Şimşek H; Örmeci N; Sonsuz A; Demir M; Kılıç M; Uygun A; Ballı T; Demir A; Arslan B; Doran F
    Oncology; 2018; 94(2):116-124. PubMed ID: 29207378
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Discordance among aggressiveness characteristics of hepatocellular carcinoma: Portal vein thrombosis and multifocality, related to tumor size, but not to serum alpha-fetoprotein level.
    Carr BI; Guerra V; Ince V; Isik B; Yilmaz S
    Liver Res; 2023 Sep; 7(3):256-262. PubMed ID: 37854945
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Trends in Tumor Indices in Relation to Increased Hepatocellular Carcinoma Size: Evidence for Tumor Evolution as a Function of Growth.
    Carr BI; Guerra V; Donghia R; Yilmaz S
    J Gastrointest Cancer; 2020 Dec; 51(4):1215-1219. PubMed ID: 33006073
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of Clinical Phenotypes and Related Survival in Patients with Large HCCs.
    Carr BI; Guerra V; Donghia R; Farinati F; Giannini EG; Muratori L; Rapaccini GL; Di Marco M; Caturelli E; Zoli M; Sacco R; Celsa C; Campani C; Mega A; Guarino M; Gasbarrini A; Svegliati-Baroni G; Foschi FG; Biasini E; Masotto A; Nardone G; Raimondo G; Azzaroli F; Vidili G; Brunetto MR; Trevisani F
    Cancers (Basel); 2021 Feb; 13(4):. PubMed ID: 33546234
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Macroscopic Portal Vein Thrombosis in HCC Patients.
    Akkiz H; Carr BI; Kuran S; Karaoğullarından Ü; Üsküdar O; Tokmak S; Arslan B; Doran F; Balli HT; Ülkü A; Akçam TA; Bahçeci Hİ; Polat KY; Örmeci N; Şimşek H; Sonsuz A; Demir A; Altıntaş E; Demir M; Yalçın K; Ekinci N; Harmancı Özakyol A; Yücesoy M; Uygun A; Guerra V; Delik A; Tokat Y; Yilmaz S; Bektaş A; Kılıç M
    Can J Gastroenterol Hepatol; 2018; 2018():3120185. PubMed ID: 30009156
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum levels of gamma-glutamyl transpeptidase in relation to HCC human biology and prognosis.
    Carr BI; Akkiz H; Bag HG; Karaoğullarından U; Yalçın K; Ekin N; Özakyol A; Altıntaş E; Balaban HY; Şimşek H; Uyanıkoğlu A; Balkan A; Kuran S; Üsküdar O; Ülger Y; Güney B; Delik A
    J Transl Sci; 2021 Jun; 7(3):. PubMed ID: 34540270
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transplant and non-transplant HCC patients at a single institution.
    Carr BI; Bag H; Ince V; Isik B; Baskiran A; Yilmaz S
    Hepatol Forum; 2024; 5(2):77-86. PubMed ID: 38487742
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Features of massive hepatocellular carcinomas.
    Carr BI; Guerra V
    Eur J Gastroenterol Hepatol; 2014 Jan; 26(1):101-8. PubMed ID: 23863262
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of abnormal plasma bilirubin with aggressive hepatocellular carcinoma phenotype.
    Carr BI; Guerra V; Giannini EG; Farinati F; Ciccarese F; Ludovico Rapaccini G; Di Marco M; Benvegnù L; Zoli M; Borzio F; Caturelli E; Chiaramonte M; Trevisani F;
    Semin Oncol; 2014 Apr; 41(2):252-8. PubMed ID: 24787296
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Low Alpha-Fetoprotein Levels Are Associated with Improved Survival in Hepatocellular Carcinoma Patients with Portal Vein Thrombosis.
    Carr BI; Guerra V
    Dig Dis Sci; 2016 Mar; 61(3):937-47. PubMed ID: 26576554
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Correlation of Clinicopathological Profile, Prognostic Factors, and Survival Outcomes with Baseline Alfa-Fetoprotein Levels in Patients With Hepatocellular Carcinoma: A Biomarker that is Bruised but Not Broken.
    Jearth V; Patil PS; Mehta S; Sundaram S; Seth V; Goel M; Patkar S; Bal M; Rao V
    J Clin Exp Hepatol; 2022; 12(3):841-852. PubMed ID: 35677513
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relationships Between Indices of Tumor Aggressiveness in Hepatocellular Carcinoma.
    Carr BI; Guerra V; Donghia R; Yilmaz S
    J Gastrointest Cancer; 2021 Dec; 52(4):1340-1349. PubMed ID: 34611834
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thrombocytopenia in relation to tumor size in patients with hepatocellular carcinoma.
    Carr BI; Guerra V; Pancoska P
    Oncology; 2012; 83(6):339-45. PubMed ID: 23006937
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.